Bernard J. Cassidy - 02 Mar 2023 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role
EVP & General Counsel
Signature
/s/ Bernard J. Cassidy
Issuer symbol
SANA
Transactions as of
02 Mar 2023
Net transactions value
$0
Form type
4
Filing time
03 Mar 2023, 15:35:27 UTC
Previous filing
16 Sep 2022
Next filing
08 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SANA Stock Options (Right to Buy) Award $0 +140,000 $0.000000 140,000 02 Mar 2023 Common Stock 140,000 $3.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 25% of the underlying shares on March 2, 2024 and in 36 equal monthly installments thereafter.